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Available online 15 October 2016Leigh syndrome (LS) is a rare, progressive neurodegenerativemitochondrial disorder of infancy. It is a genetically
heterogeneous disease. The mutations in SURF1 gene are themost frequently known cause. Here two cases of LS
likely caused by SURF1 gene variants are reported: a 39-year-oldmale patient with a novel homozygous deletion
(c.-11_13del), and a case of a 6-year-old boy with the same deletion and a nonsense mutation (c.868dupT), both
in heterozygosity. Blue native PAGE showed absence of assembled complex IV. This is the ﬁrst report of a variant
that may abolish the SURF1 gene initiation codon in two LS patients.







Leigh syndrome (LS) (OMIM #256000), ﬁrst described in 1951, is
characterized by focal, symmetrical, and necrotic lesions in the thala-
mus, the brain stem, and the posterior columns of the spinal cord
(Munnich et al., 1996; Munnich et al., 2012). The neuropathological di-
agnosis has been replaced by brain magnetic resonance imaging (MRI),
which exhibits typical lesions (Tiranti et al., 1999). Usually, LS presents
at an early age with psychomotor regression, pyramidal and extrapyra-
midal symptoms and signs of brain stem dysfunction, such as apnea and
other respiratory rhythm abnormalities. Several inborn errors of energy
metabolism, such as pyruvate dehydrogenase and mitochondrial respi-
ratory chain (MRC) deﬁciencies have been associated with LS, although
in some cases the cause cannot be identiﬁed. One of the most common
enzymatic deﬁciencies associated to LS is cytochrome c oxidase (COX,
complex IV) dysfunction (Piekutowska-Abramczuk et al., 2009).
Mutations in nuclear genes – SURF1, SCO1, SCO2, COX10, COX15,
LRPPRC, PDHA1 – have been associated to LS (Finsterer, 2008). Accord-
ing to Agostino et al. (2003), the most common genetic cause in LS pa-
tients with complex IV deﬁciency involves SURF1 gene. The association
between SURF1 mutations and LS seems rather speciﬁc, since noity of Coimbra, Pólo III– Subunit
gal.
e@gmail.com (M. Grazina).
ch Society. All rights reserved.alterations in SURF1 are usually detected in complex IV deﬁciency pa-
tients with other clinical presentations (Agostino et al., 2003). The
SURF1 gene is located at chromosome 9p34, in a cluster referred as the
“surfeit” genes that are highly conserved throughout evolution (Duhig
et al., 1998). It encodes a mitochondrial inner membrane protein with
300 amino acids (Piekutowska-Abramczuk et al., 2009) that is involved
in the assembly andmaintenance of complex IV (Kovárová et al., 2012).
2. Materials and methods
2.1. Clinical subjects
This study was conducted during the diagnostic investigation of the
genetic cause of the disease and informed consent was obtained from
the participants or their legal representatives, as recommended by the
local Ethics Committee, following the Tenets of theHelsinki Declaration.
2.2. SURF1 gene sequencing
After extracting genomic DNA from whole blood of the affected pa-
tients and their parents, SURF1 sequencing was performed following
standard techniques. The identiﬁed deletion (according to
NM_003172) was conﬁrmed by PCR-RFLP (Supplementary File). The
newly described deletion has been submitted to ClinVar (http://www.
ncbi.nlm.nih.gov/clinvar/).
Fig. 1. Radiological features of patient 1: axial T2-weighted images (T2WI) (A–C) showing (A) hyperintense lesion (arrow) in the head of the left caudate nucleus; (B) symmetrical
involvement of the midbrain tegmentum (arrow); (C) involvement of periaqueductal gray matter (circle). Radiological features of patient 2: Axial T2WI (D–I) showing bilateral
hyperintense lesions (indicated by arrows) of the head of the caudate nuclei (D) and the thalamic posteromedial ventral nuclei (E). Symmetrical involvement of the dorsal midbrain
(F), dorsal pons and deep cerebellar white matter (G) and olivary nuclei (H) is also noted. Coronal T2WI shows additional lesion of the left dentate nucleus.
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Fibroblasts from the patients with SURF1 mutations were used to
evaluate assembly of MRC complex IV monomers, using the methodol-
ogy previously reported for BN-PAGE analysis (Calvaruso et al., 2008)
with modiﬁcations (Supplementary File).
3. Results
Patient 1 is a Caucasian male patient, born at term in 1976, from a
healthy non-consanguineous couple. Family history is irrelevant, except
for diabetes mellitus on maternal lineage. At 2 years of age unilateral
strabismus was noticed and by 3–4 years dysarthria, ataxia, kinetic
tremor and slight hypotonia developed. At 8 years of age, an acute dete-
rioration with shock, coma, central apnea and ophthalmoparesis
emerged, after proctated vomiting. Etiological investigation, namely in-
fectious andmetabolic, was inconclusive. Computed tomography of the
brain was normal and MRI showed moderate cerebellum atrophy. Pro-
gressive recovery ensued, except for right hemidystonia. At 21 years of
age the patient experienced a sudden, non painful, loss of vision and
the diagnosis of retinal central vein thrombosis was made.
Thrombophilia screening was negative. Laboratory investigation re-
vealed increased lactate and lactate/pyruvate ratio, moderate complexIV deﬁciency in lymphocytes – 29.7% of average control value corrected
for citrate synthase (criteria according to Grazina, 2012). Five years
later, in the sequence of an acute pharyngitis, this patient developed
central hipoventilation lead to respiratory insufﬁciency with need for
chronic mechanical ventilation. Brain-MRI revealed the typical lesions
observed in LS (Fig. 1A–C). Muscle biopsy study disclosed no histology
abnormalities and low complex IV activity – 22.5% of average control
value corrected for citrate synthase (criteria according to Grazina,
2012).
The SURF1 gene investigation revealed a homozygous deletion of 24
nucleotides, c.-11_13del (Fig. 2A and C). This alteration was absent in
200 DNA samples of healthy subjects and it was not reported in any
public SNP databases or in recent publications (Lee et al., 2012;
Wedatilake et al., 2013). The deletion is located in a highly conserved re-
gion (Fig. 2E) and causes the loss of ATG codon, essential for the protein
synthesis initiation (Fig. 2D). Patient's 1mother SURF1 screening identi-
ﬁed the deletion in heterozygosity; the DNA sample from the fatherwas
not available for analysis.
Patient 2 is a 6-year-old boy, born in 2009, at term from healthy,
non-consanguineous parents, with irrelevant family history. At 3 years
of age he presented in coma with respiratory acidosis, in the sequence
of rhinopharyngitis and vomiting. He had been followed in the outpa-
tient clinic from two years of age due to failure to thrive, strabismus,
EF
86 C. Ribeiro et al. / Mitochondrion 31 (2016) 84–88
87C. Ribeiro et al. / Mitochondrion 31 (2016) 84–88and ataxia, with loss of motor milestones. The brain-MRI revealed le-
sions typical of LS and Magnetic Resonance Spectroscopy, lactate
peaks (Fig. 1D–I).
Laboratory investigation disclosed normal lactate, glycaemia,
creatinine kinase, amino acids and organic acids. Later on, increased
lactate and lactate/pyruvate ratio were detected. Complex IV activity
in lymphocytes was 20.2% of average control value corrected for cit-
rate synthase (criteria according to Grazina, 2012). Isolated complex
IV deﬁciency was detected in the muscle biopsy – 18.4% of average
control value corrected for citrate synthase (criteria according to
Grazina, 2012). Investigation of SURF1 revealed a heterozygous dele-
tion, c.-11_13del (Fig. 2A), and a heterozygous T duplication,
c.868dupT (Fig. 2B). The c.868dupT is absent in 200 samples of
healthy subjects and is located in a highly conserved region (Fig.
2F). This alteration was previously reported in LS patients (Tiranti
et al., 1998; Kinghorn et al., 2013; Aulbert et al., 2014). Each parent
is a carrier (heterozygous) for one of those alterations (c.-11_13del
in the father and c.868dupT in the mother).
The BN–PAGE experiments demonstrated the absence of assembled
complex IV in patients' samples (Fig. 2G).
4. Discussion
The SURF1 is embedded in a cluster of 6 housekeeping genes (the
surfeit locus, SURF1 to 6) and the structure of this cluster is unique in
the mammalian genome (Huxley and Fried, 1990). This basic structure
has been conserved during evolution, suggesting that it has a functional
importance in coordinating gene expression regulation. So far, N78mu-
tations were found in SURF1, and about 80% probably lead to the pro-
duction of truncated proteins, mainly due to aberrant splicing,
frameshift, deletions or nonsense mutations (Wedatilake et al., 2013).
Themajority of SURF1mutations previously associated to LS, are located
in exon 8, suggesting that this region has an important impact in the
protein function or it is a hot spot for the occurrence of mutations
(Lee et al., 2012).
So far, the deletion found is a novel variant and it is one of the largest
rearrangements reported for SURF1 gene. The precise functional conse-
quences of the c.-11_13del are difﬁcult to predict, but with the loss of
the ﬁrst codon, it is possible that another ATG sequence may be recog-
nized as the protein initial codon, probably signiﬁcantly altering the
SURF1protein (Surf1p). Nevertheless, the BN-PAGE results demonstrat-
ing the absence of assembled complex IV in patients’ ﬁbroblasts’ sam-
ples, reinforce and support the deleterious role of the mutations,
particularly the novel deletion c.-11_13del, herein described.
In 1999, Tiranti et al. evaluated the expression of SURF1 gene at the
mRNA level in LS patients carrying different mutations of the gene.
They have concluded that differentmutations spanning theﬁrst 770 nu-
cleotides of SURF1 lead to the absence of transcript. These results sug-
gested that alterations in the initial region of the gene are probably
associated with severe mRNA instability (Tiranti et al., 1999), which
might be also occurring with the identiﬁed deletion SURF1 transcripts
of the present work.
It is important to emphasize the current age of patient 1: 39 year-old.
To our knowledge, it is the oldest patient ever reported with LS associ-
ated to SURF1 mutations. Patients with SURF1-associated LS have a
poor prognosis and usually die in the ﬁrst decade of life (Lee et al.,
2012). According to Aulbert et al. in 2014, a total of 15 patientswith sur-
vival higher than 14 years have been reported and the oldest patientFig. 2. (A) Electropherogramof the region surrounding the deletion c.-11_13del in patient 1 (a),
alteration in patient 2 (a) and a control (b); (C) PCR-RFLP of c.-11_13del mutation: 1 - pUC19
mother; 4 - Patient's 2 mother; 5 - Patient 2; 6 - Patient's 2 father; 7 - Control sample, 8 - No
Schematic representation of Surf1p, SURF1 gene 5′UTR and initial codons with the deletion c.-
sequence; (E) Nucleotide evolutionary conservation study for SURF1 gene c.-11_13del m
nucleotides and uppercase indicates the exon 1; (F) Nucleotide and amino acid evolutionary
p.Lys291X. Nucleotide underlined and in bold indicate the duplicated nucleotide, “X” indicate
of ﬁbroblasts' samples (from controls, Ct, and patients, P1 and P2); *p b 0.05.with LS associated to SURF1 mutations was a woman with 22 years
old (Lee et al., 2012; Aulbert et al., 2014). This patient had two muta-
tions that were predicted to generate truncated proteins at amino acid
positions 248 and 279. According to the authors, the milder phenotype
could be explained by the fact that those alterations occur near the C-
terminus of the protein and it could have some residual function (Lee
et al., 2012).
Considering that patient 1 has a predictably deleterious SURF1 dele-
tion in homozygosity, his long survival can be due to a possible compen-
satorymechanism that counterbalances Surf1p function in the assembly
of complex IV (Shoubridge, 2001; Dell'Agnello et al., 2007). Kovárová et
al. detected two dominant complex IV forms in SURF1-mutant patients'
ﬁbroblasts: a large amount of COX1 assembly intermediates and the
majority of fully assembled complex IV were in I-III2-IVn
supercomplexes. By contrast, the human control ﬁbroblasts complex
IV is mainly found as a monomer (Kovárová et al., 2016). This report
supports the lack of assembled complex IV (as a monomer) found in
P1 and P2 patients and may explain the residual activity of complex IV
(% of control activity, respectively for P1 and P2: 22.5% and 18.4% -
muscle; 26.4% and 25.8% - ﬁbroblasts).
Patient 2 has a compound heterozygous mutation with the c.-
11_13del and the c.868dupT in exon 9. This duplication is predicted to
generate a stop codon in amino acid 291 (p.Lys291X), resulting in a pro-
tein possibly smaller in 9 amino acids compared to the normal Surf1p.
According to Tiranti et al. (1999), this alteration generates a truncated
protein with residual complex IV activity (Tiranti et al., 1999). The re-
ported deﬁciency may be due to a loss of Surf1p conserved C-terminus
transmembrane domain integrity. The phenotype of patient 2 is expect-
ed to be due to the combination of the compound heterozygous muta-
tions found.
In conclusion, in this work two alterations are reported: the
c.868dupT and a novel deletion (c.-11_13del) in the 5′UTR region and
the initially coding nucleotides of SURF1 gene. This deletion is the ﬁrst
alteration reported in this region and possibly leading to the loss of
the ATG codon, although the consequences for Surf1p expression will
only be clear after performing additional functional studies. Patient 1
presents only the novel deletion in homozygosity and, to our knowl-
edge, this is the oldest patient reported with SURF1mutations possibly
associated to LS. The long survival of this patient can be possibly ex-
plained by an alternative compensatory mechanism that counterbal-
ances Surf1p function in the complex IV assembly.
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